Acquisition Announced
Danaher acquisition of Masimo
US$9.9bn enterprise value
Announced 17 Feb 2026 · NASDAQ: MASI · US$180.00 cash per share · 38% premium
Advisers
Masimo
Target
- Financial adviser
- Legal adviser
- Communications
- Fairness opinion
Investor
- Legal adviser
- Target
- Masimo
- Acquirer
- Danaher
- Target based in
- United States
- Buyer based in
- United States
- Sector
- Medtech
- Tags
- Medtech, Diagnostics
In the league tables
Similar deals
- Halma acquisition of Dreampath Diagnostics Jul 2026 · Diagnostics
- AMETEK acquisition of LKC Technologies Feb 2026 · Medtech
- Timothy R. Damadian acquisition of FONAR Dec 2025 · Medtech
- Merck KGaA acquisition of Bio-Techne Jun 2026 · US$11bn · Life Sciences
- Curium US Holdings acquisition of Lantheus Holdings Aug 2026 · US$8bn · Radiopharmaceuticals
Sources
- 2026 Centerview Partners: Financial advisor to Masimo Corporation on its sale to Danaher centerviewpartners.com
- Feb 2026 Kirkland Advises Danaher on $9.9 Billion Acquisition of Masimo kirkland.com
- 17 Feb 2026 Press release (EX-99.1, exhibit), Innovation at the speed of life. sec.gov
- 17 Feb 2026 Press release (EX-99.1, exhibit), Masimo to be Acquired by Danaher for $180.00 sec.gov
- 17 Feb 2026 Press release (PR Newswire), Danaher To Acquire Masimo Corporation prnewswire.com
- 18 Mar 2026 Preliminary merger proxy statement (PREM14A), MASIMO CORP sec.gov
- 1 Apr 2026 Definitive merger proxy statement (DEFM14A), MASIMO CORP sec.gov





